Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals.

We document the existence of rare cases of hepatitis C-infected patients with significant uroporphyrinuria in the absence of dermatological manifestations. Anti-viral therapy normalises the biochemical disorder, preventing patients from presenting PCT associated complications.